A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. (Q39166286)

9 September 2017

A Randomized Controlled Trial Comparing the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. (English)

1 reference

randomized controlled trial

9 September 2017

1 reference

Shanti L Eswaran

1

1 reference

9 September 2017

William D Chey

2

1 reference

9 September 2017

Theresa Han-Markey

3

1 reference

9 September 2017

Sarah Ball

4

1 reference

9 September 2017

Kenya Jackson

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

11 October 2016

1 reference

The American Journal of Gastroenterology

9 September 2017

1 reference

9 September 2017

111

1 reference

9 September 2017

12

1 reference

9 September 2017

1824-1832

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2016.434

9 September 2017

0 references

cites work

The functional gastrointestinal disorders and the Rome III process

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Review article: epidemiology and quality of life in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Costs of irritable bowel syndrome in the UK and US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Irritable bowel syndrome: a clinical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Food: the forgotten factor in the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

A diet low in FODMAPs reduces symptoms of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Comparison of symptom response following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Comparative advantage of 3-day food records over 24-hour recall and 5-day food frequency validated by observation of 9- and 10-year-old girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Long-term safety and efficacy of alosetron in women with severe diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

A review of validations of dietary assessment methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2016.434

Irritable bowel syndrome and hypersensitivity to food.

21 January 2018

1 reference

12 December 2020

Diets that differ in their FODMAP content alter the colonic luminal microenvironment

1 reference

12 December 2020

Food hypersensitivity in irritable bowel syndrome

1 reference

12 December 2020

Utility of the Rome I and Rome II criteria for irritable bowel syndrome in U.S. women

1 reference

12 December 2020

Food allergy and the irritable bowel syndrome

1 reference

12 December 2020

Issues in reproducibility and validity of dietary studies

1 reference

12 December 2020

Eluxadoline for Irritable Bowel Syndrome with Diarrhea

1 reference

12 December 2020

Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome

1 reference

12 December 2020

Dietary poorly absorbed, short-chain carbohydrates increase delivery of water and fermentable substrates to the proximal colon

1 reference

12 December 2020

FODMAPs alter symptoms and the metabolome of patients with IBS: a randomised controlled trial

1 reference

12 December 2020

Identifiers

DOI

10.1038/AJG.2016.434

1 reference

Dimensions Publication ID

9 September 2017

0 references

1 reference